SYP and Alzheimer disease: Further exploration of electrophysiological consequences of Aβ-induced synaptophysin loss, as well as how pathological Aβ derived from human AD cases differs to synthetic Aβ, will be highly informative and help direct future studies to the best treatment type to accurately model AD-like changes.